Rate My Professor Dorry Segev

Segev's research specializes in outcomes, disparities, and allocation policies in solid organ transplantation, employing advanced statistical methods such as informative censoring, competing risks, multilevel models, and longitudinal data analysis to address biases in medical inferences. He developed a mathematical model facilitating nationwide kidney paired donation programs across the US and Canada, demonstrated the survival benefit of HLA-incompatible kidney transplantation, and orchestrated the first HIV-to-HIV kidney transplant in the United States, contributing to the passage of the HIV Organ Policy Equity (HOPE) Act. His influential publications include 'Frailty as a predictor of surgical outcomes in older patients' (Journal of the American College of Surgeons, 2010), 'Risk of end-stage renal disease following live kidney donation' (JAMA, 2014), 'Desensitization in HLA-incompatible kidney recipients and survival' (New England Journal of Medicine, 2011), and contributions to KDIGO clinical practice guidelines on living kidney donors (Transplantation, 2017) and kidney transplant candidates (2020). Segev was elected to the National Academy of Medicine in 2019 and holds the Pozefsky Professorship in Kidney Transplant Surgery. His work has significantly advanced transplant epidemiology, policy, and clinical practice through high-impact studies on donor risks, frailty, sarcopenia, and vaccine responses in transplant recipients.